Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

from period to period

in a meaningful and consistent manner. Due to the frequency of

their occurrence in its business, the Company does not adjust net

income or loss for the costs associated with litigation, including

payments made or received through settlements. It should be noted

that "net income or loss on an adjusted cash basis" is not a

standard financial measurement under accounting principles generally

accepted in the United States of America ("GAAP") and should not be

considered as an alternative to net income or loss or cash flow from

operating activities, as a measure of liquidity or as an indicator

of operating performance or any measure of performance derived in

accordance with GAAP. In addition, all companies do not calculate

non-GAAP financial measures in the same manner and, accordingly,

"net income or loss on an adjusted cash basis" presented in this

press release may not be comparable to similar measures used by

other companies.

(b) Amortization expense of $155.1 million and $36.4 million in the

first nine months of 2008 and 2007 GAAP results, respectively,

including $34.2 million and $13.8 million charged to cost of sales,

$2.8 million and $2.1 million charged to research and development

and $117.4 million and $20.2 million charged to selling, general and

administrative, in the respective periods, with $0.7 million and

$0.3 million charged through equity earnings of unconsolidated

entities, net of tax during the nine months ended September 30, 3008

and 2007, respectively.

( c ) Restructuring charges associated with the decision to close

facilities of $45.7 million and $1.5 million in the first nine

months of 2008 and 2007 GAAP results
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Three Lawrence Livermore ... Hydrogen Production R&D Award for their ... water using sunlight. , Shared with collaborators from ... University of Nevada, Las Vegas (UNLV), the award ... of photoelectrochemical solar-hydrogen production and corrosion processes. , ...
(Date:8/29/2014)... Due to a misstatement posted by the Family ... Technology Center, LLC ( ASCTC ) was reported as an ... might benefit ALS patients. Because of ASCTC's exclusive focus ... and therapeutic applications, FRC listed ASCTC as one of several ... wish not to support research that requires the death of ...
(Date:8/29/2014)... A major challenge before new biotechnology start-up companies, ... Boston-Cambridge, is gaining visibility that can lead to important ... of Boston’s Adult Stem Cell Technology Center, LLC (ASCTC), ... his company an important priority since he started the ... social media marketing campaign launched earlier in ...
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
Breaking Biology Technology:Livermore Team Awarded for Hydrogen Production Research 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... the SciVerse ScienceDirect eBooks Collection 2011 Frontlist -- ST. LOUIS, November 15, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... N.C., Nov. 15, 2010 Talecris Biotherapeutics (Nasdaq: ... data from two studies demonstrating that augmentation therapy with ... in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency. ... of the raw data from two similar pilot trials, ...
... ... ... var shortURL = ""; BitlyCB.alertResponse = ... the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) ...
Cached Biology Technology:Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 2Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 3Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 4Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 5Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 6Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 7Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 8Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 9Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 10Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 2Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 3Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 4Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 5MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 2MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 3MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 4MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 5MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 6MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 7MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 8MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 9
(Date:8/28/2014)... Invasives is now available from the Lady Bird Johnson ... for identifying harmful non-native plant, insect and other invasive ... States cause about $137 billion in economic and other ... kill native plants and more. , "By having streamlined ... invasive species occur, we,re more likely to catch these ...
(Date:8/28/2014)... pleased to announce the selection of Dr. Fred Baxendale ... acknowledges those who have served ESA for at least ... the Society that has reached an extraordinary level. Candidates ... Board and then voted on by the ESA membership. ... at Entomology 2014, ESA,s Annual Meeting in Portland, Oregon ...
(Date:8/28/2014)... bacterial culprits that may drive inflammatory bowel diseases (IBD) ... own intestinal immune responses as a guide. , The ... Cell . , Trillions of bacteria exist within the ... the development and progression of IBD. Yet it,s thought ... a person,s susceptibility to IBD and its potential severity. ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Yale study identifies possible bacterial drivers of IBD 2
... gene transcription the process inside the nucleus of cells ... molecules a large, ever-changing multiprotein complex is enlisted to ... Like an exquisitely choreographed dance, each step in the process ... copy to be accurate and useful in subsequent events. ...
... Among the 75 people Esquire magazine recently ... are three researchers in an emerging discipline that combines ... novel biological functions and systems otherwise known as ... scientific field lies in the potential to apply engineering ...
... "Life happens at the level of proteins . ... polymerize, repair, support, modify, degrade, fold, migrate, and transport; ... carry, and repress; they bind, transfer, translocate, amplify, proofread, ... is from the preface of the new book ...
Cached Biology News:CSHL scientists discover new way in which ubiquitin modifies transcriptional machinery 2New manual presents robust, state-of-the-art proteomics methods for teaching and research 2
... your microarray data using Asuragens bioinformatics expertise. ... consultation to extensive data analysis using the ... expertise in combination with the Gene Expression ... experiments., ,Normalization and basic statistical analysis including ...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap. (2/sp, 20/ca) Packaging: 2 / pack, 20 /...
... Time of Flight Mass Analyzer for superior sensitivity, mass accuracy, and ... 25,000 m/z, * Precursor ion selection range: 150 - 4000 m/z, ... ppm with internal reference, * Dynamic range: 4 orders of magnitude ... ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Biology Products: